Connect with Fogarty
The Fogarty International Center, part of the U.S. National Institutes of Health (NIH), supports basic, clinical and applied research and training for U.S. and foreign investigators working in the developing world.
To protect the health and safety of Americans, Fogarty has for three decades managed grant programs that develop scientific expertise in developing countries, ensuring there is local capacity to detect and address pandemics at their point of origin, contain outbreaks and minimize their impact.
Over the decades, Fogarty’s programs have made significant contributions by filling the pipeline of global health leaders, extending the frontiers of science and accelerating discovery.
Over the course of his 27 years in Congress, Rep. John Edward Fogarty (D-RI) was a champion for NIH and for the value of medical research.
When Ebola struck West Africa in 2014, countries with little or no scientific capacity suffered the most, and the cost of the U.S. response to help them soared above $2 billion. A new Fogarty program is aimed at strengthening scientific expertise at institutions in Guinea, Liberia and Sierra Leone so that when the next outbreak comes, they will be prepared to rapidly respond.
As a Fogarty Fellow, Dr. Gilberte Bastien is working with Ebola survivors in Liberia to deal with the mental health challenges they face.
Research conducted in Colombia, South America may provide clues on how to prevent the ravages of Alzheimer's disease. Fogarty helped set the stage for an innovative Alzheimer's prevention trial by supporting the training of Colombian scientists in cutting-edge neuroscience research.
Fogarty has partnered with the Fulbright Program, the flagship international educational exchange program sponsored by the U.S. government, to promote the expansion of research in public health and clinical research in resource-limited settings for medical and graduate students.
A former Fogarty trainee who conducts research in the Peruvian Amazon is part of a multi-site NIH trial to evaluate a Zika vaccine candidate.
In Brazil, Fogarty-supported scientists rapidly changed gears from working on Chagas disease and dengue to studying Zika virus, which was suspected of causing birth defects.
Expertise developed through Fogarty's research training programs helped to make a landmark multi-site international HIV study possible.
Fogarty has provided broad support for malaria researchers, funding or administering nearly 900 grants that were either entirely focused on malaria research training or included a malaria component.
Updated May 16, 2017
To view Adobe PDF files, download current, free accessible plug-ins from Adobe's website.